Company Profile
Novabay Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- NBY
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for NBY.
Company overview
Business overview
NovaBay Pharmaceuticals is a specialty pharmaceutical company focused on eye care and skin/dermatology products. Its business has centered on commercial products and niche healthcare applications rather than broad biotech discovery.
Geographic Base and Sector Classification
NovaBay is headquartered in the United States and listed on NYSE American. It sits in specialty pharma and eye-care healthcare products.
Business Model Characteristics
The company depends on product sales, channel execution, and the ability to keep a narrow commercial portfolio relevant. Investors usually watch revenue, distribution, and strategic changes.
Position Within the Biotechnology Landscape
NovaBay occupies a small specialty-pharma niche within healthcare. It is more commercial than development-stage biotech and tends to move on product execution.
Future catalysts
NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it as a live growth name.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Novabay Pharmaceuticals do?
NovaBay Pharmaceuticals is a specialty pharmaceutical company focused on eye care and skin/dermatology products. Its business has centered on commercial products and niche healthcare applications rather than broad biotech discovery.
On which exchange is NBY stock listed?
Novabay Pharmaceuticals (NBY) is associated with AMEX, United States, Biopharma.
What is NovaBay?
NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update.
Which conditions is Novabay Pharmaceuticals targeting with NovaBay?
Novabay Pharmaceuticals is associated with dermatology based on its company overview and current catalyst commentary.
How does Novabay Pharmaceuticals describe recent progress with NovaBay?
NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update.
What is Pharmaceuticals?
NovaBay Pharmaceuticals is a specialty pharmaceutical company focused on eye care and skin/dermatology products.
What should investors watch for with Pharmaceuticals?
NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it as a live growth name.
What future catalysts are investors watching for Novabay Pharmaceuticals?
NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it as a live growth name.